New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

PSCHvsLFSCETF Comparison

ETF 1
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
-1.91%
Full PSCH fund page
VS
ETF 2
LFSC

F/m Emerald Life Sciences Innovation ETF

This fund is part of
Life Sciences
-3.41%
Full LFSC fund page

Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. F/m Emerald Life Sciences Innovation ETF (LFSC) is part of the Life Sciences segment. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.79% for LFSC. PSCH is down -9.57% year-to-date (YTD) with -$14M in YTD flows. LFSC performs better with -7.57% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of PSCH and LFSC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PSCH vs LFSC performance and flow charts

Performance

-6.0-4.0-2.00.02.04.0%Feb 12Feb 20Feb 27Mar 6

Cumulative Flows

-10 M-5 M0 M5 MFeb 12Feb 20Feb 27Mar 6

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
PSCH
LFSC
-4.98%-5.12%
-13.47%-13.36%
-9.57%-7.57%
-4.84%+48.56%
-5.55%n/a
-37.27%n/a
Flows
PSCH
LFSC
-$12M+$6M
-$15M+$6M
-$14M+$5M
-$33M+$16M
-$168M-
-$230M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
PSCH
LFSC
+19.05%+22.88%
+23.19%+28.76%
+21.52%n/a
+22.79%n/a
Max drawdown
PSCH
LFSC
-13.93%-13.77%
-13.93%-19.03%
-23.50%n/a
-47.23%n/a
Max drawdown duration
PSCH
LFSC
80d77d
80d70d
449dn/a
1719dn/a
Trading data

Create an account to view trading data

Join for free
PSCH
LFSC
Last sale
3/12/2026 at 1:30 PM
$39.81
$33.82
Previous close
03/12/2026
$41.15
$35.01
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

LFSC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PSCH
LFSC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
PSCH
LFSC
Last price
$39.81
$33.82
1D performance
-3.26%
-3.41%
AuM$120.40 M$90.59 M
E/R0.29%0.79%
Characteristics
PSCH
LFSC
Management strategyPassiveActive
ProviderInvescoEmerald Group
BenchmarkS&P SmallCap 600 Capped Health Care Index-
N° of holdings7134
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateApril 7, 2010October 31, 2024
ESGNoNo
Advertisement
Exposure

Countries

PSCH
USA
95.98%
Other
4.02%
LFSC
USA
88.44%
Other
11.56%

Sectors

PSCH
Health Care
91.17%
Other
8.83%
LFSC
Health Care
86.26%
Other
13.74%

Diversification

PSCH

Total weight of top 15 holdings out of 15

43.5%
LFSC

Total weight of top 15 holdings out of 15

68.94%

Top 15 holdings

Data as of January 31, 2026
PSCH
ARROWHEAD PHARMACEUTICALS INC
4.98%
KRYSTAL BIOTECH INC
3.88%
GLAUKOS
3.85%
PTC THERAPEUTI/D
3.30%
ALKERMES
2.95%
RADNET
2.78%
MERIT MEDICAL SYSTEMS
2.64%
PROTAGONIST THERAPEUTICS INC
2.61%
TRANSMEDICS GROUP
2.57%
TELEFLEX
2.48%
US10950A1060
2.46%
CORCEPT THERAPEUTICS
2.31%
US45579U1097
2.26%
TG THERAPEUTICS
2.25%
ADMA BIOLOGICS INC
2.18%
LFSC
COGENT BIOSCIENCES
9.06%
LIVANOVA
6.76%
GUARDANT HEALTH INC
5.62%
MIRUM PHARMACEUTICALS INC
5.37%
TRANSMEDICS GROUP
5.18%
WAVE LFE SCIEN
4.81%
TRAVERE THERAPEUTICS INC
4.77%
BRIDGEBIO PHARMA
3.92%
SAVARA INC
3.82%
ICU MEDICAL
3.60%
KALVISTA PHARMACEUTICALS INC
3.59%
UTD THERAPEUT
3.56%
US00773J2024
3.44%
MADRIGAL PHARMACEUTICALS INC
2.86%
ACADIA PHARMACEUTICALS
2.58%
Frequently asked questions about PSCH and LFSC

How have the PSCH and LFSC ETFs performed in 2026?

As of March 12, 2026, PSCH is down -9.57% year-to-date (YTD), while LFSC has lost -7.57%. That puts LFSC better performer ahead so far this year.

Which ETF is attracting more investor money: PSCH or LFSC?

Year-to-date, the PSCH ETF saw -$14M in flows, compared to +$5M for LFSC.

Which ETF is more volatile: PSCH or LFSC?

Over the past year, PSCH had a volatility of 23.19%, while LFSC experienced 28.76%.

Which ETF is bigger: PSCH or LFSC?

As of March 12, 2026, PSCH holds $120.40 M in assets under management (AUM), while LFSC manages $90.59 M.

What sectors do the PSCH and LFSC ETFs invest in?

PSCH leans toward sectors like Health Care. Meanwhile, LFSC focuses on Health Care.

What are the top holdings of the PSCH ETF and LFSC ETF?

PSCH top holdings include ARROWHEAD PHARMACEUTICALS INC, KRYSTAL BIOTECH INC and GLAUKOS. LFSC holds in its top three: COGENT BIOSCIENCES, LIVANOVA and GUARDANT HEALTH INC.

Which ETF is more diversified: PSCH or LFSC?

PSCH holds 75 securities with 43.5% of its assets in the top 15. LFSC has 42 securities and a top 15 weight of 68.94%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast